Tawnie J. Braaten
( out of 218 reviews )

Tawnie J. Braaten, MD

Languages spoken: English

Clinical Locations

Sugar House Health Center

Salt Lake City
801-581-2000
Directions

University of Utah Hospital

Rheumatology, Area E
Salt Lake City
801-581-7724
Directions

  • Tawnie J. Braaten, M.D., is an Assistant Professor in the Division of Rheumatology, Department of Internal Medicine at the University of Utah and the SLC Veterans Affairs Medical Center. She is a general clinical rheumatologist who sees patients with all forms of rheumatic disease. She has a special interest in patients who developed immune related adverse events secondary to immunotherapy treatment for cancer.

    She received a Bachelor’s degree in Chemistry at Concordia College in Moorehead, MN and her medical degree from the University of Washington School of Medicine in Seattle, WA. She completed her internal medicine residency and rheumatology fellowship at the University of Utah School of Medicine in Salt Lake City, UT. During her fellowship she gained a special interest in immune related adverse events secondary to immunotherapy. This led her to do a postdoctoral fellowship at The Johns Hopkins University in Baltimore, MD to develop her knowledge and skill set in caring for those with rheumatic immune related adverse events. Throughout this post-doctoral fellowship she actively cared for patients with rheumatologic immune related adverse events and worked on expanding their established cohort to better understand these novel conditions. During this time Dr. Braaten worked with the experts of this field at one of the main institutions actively pursuing treatment of these difficult cases. She has continued to care for individuals with rheumatic immune related adverse events in her current practice here at the University of Utah and is developing a cohort to continue to study these disease processes. She is also part of a consortium in which multiple institutions are collecting similar data on these patients to better understand the different clinical phenotypes, treatment responses, and outcomes.

    Dr. Braaten joined the University of Utah School of Medicine in 2019.

    Specialties

    Board Certification

    American Board of Internal Medicine
    American Board of Internal Medicine (Sub: Rheumatology)

    Patient Rating

    5.0 /5
    ( out of 218 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety. For the convenience of our visitors, some patient comments have been translated from their original language into English while preserving their original meaning as accurately as possible. Patients are de-identified for confidentiality and patient privacy.

    January 18, 2025
    SUGAR HOUSE HEALTH CENTER

    Dr. Brataan is great! [TRANSLATED]

    January 15, 2025
    UNIVERSITY HOSPITAL

    Dr. Tawnie Braaten, the best rheumatologist and her staff very courteous nice. I recommend my specialist Dr. Tony Braaten to everybody.

    January 15, 2025
    UNIVERSITY HOSPITAL

    Listened to concerns I had & answered questions in a language I understood

    December 11, 2024
    UH HOSPITALS AND CLINICS

    Friendly and easy to understand. I like her very much.

    December 11, 2024
    UH HOSPITALS AND CLINICS

    She is always able to narrow in on focus on the issues that are bothering me. She helps me recognize what I need to do, to do a better job.

    November 10, 2024
    SUGAR HOUSE HEALTH CENTER

    She is an amazing doctor and is very knowledgeable in her field. I would recommend her to anyone that needs help within her profession.

    November 06, 2024
    UH HOSPITALS AND CLINICS

    Super Lady who goes above and beyond about her patients care.

    November 03, 2024
    UH HOSPITALS AND CLINICS

    Dr Braaten is a very competent, clear talking doctor who I feel takes good care of my needs.

    November 03, 2024
    UH HOSPITALS AND CLINICS

    Dr. Braaten is knowledgeable, provides clear explanations and is very pleasant to interact with. I strongly recommend her.

  • Tawnie J. Braaten, M.D., is an Assistant Professor in the Division of Rheumatology, Department of Internal Medicine at the University of Utah and the SLC Veterans Affairs Medical Center. She is a general clinical rheumatologist who sees patients with all forms of rheumatic disease. She has a special interest in patients who developed immune related adverse events secondary to immunotherapy treatment for cancer.

    She received a Bachelor’s degree in Chemistry at Concordia College in Moorehead, MN and her medical degree from the University of Washington School of Medicine in Seattle, WA. She completed her internal medicine residency and rheumatology fellowship at the University of Utah School of Medicine in Salt Lake City, UT. During her fellowship she gained a special interest in immune related adverse events secondary to immunotherapy. This led her to do a postdoctoral fellowship at The Johns Hopkins University in Baltimore, MD to develop her knowledge and skill set in caring for those with rheumatic immune related adverse events. Throughout this post-doctoral fellowship she actively cared for patients with rheumatologic immune related adverse events and worked on expanding their established cohort to better understand these novel conditions. During this time Dr. Braaten worked with the experts of this field at one of the main institutions actively pursuing treatment of these difficult cases. She has continued to care for individuals with rheumatic immune related adverse events in her current practice here at the University of Utah and is developing a cohort to continue to study these disease processes. She is also part of a consortium in which multiple institutions are collecting similar data on these patients to better understand the different clinical phenotypes, treatment responses, and outcomes.

    Dr. Braaten joined the University of Utah School of Medicine in 2019.

    Board Certification and Academic Information

    Academic Departments Internal Medicine -Assistant Professor (Clinical)
    Academic Divisions Rheumatology
    Board Certification
    American Board of Internal Medicine
    American Board of Internal Medicine (Sub: Rheumatology)

    Education history

    Postdoctoral Fellowship Rheumatology - The Johns Hopkins University Postdoctoral Fellow
    Fellowship Rheumatology - University of Utah School of Medicine Fellow
    Residency Internal Medicine - University of Utah School of Medicine Resident
    Professional Medical Medicine - University of Washington School of Medicine M.D.
    Undergraduate Chemistry - Concordia College B.A.

    Selected Publications

    Journal Article

    1. Thompson JA, Schneider BJ, Brahmer J, Zaid MA, Achufusi A, Armand P, Berkenstock MK, Bermas B, Braaten T, Budde LE, Chokshi S, Crees ZD, Davies M, Deng C, Gesthalter Y, Jain M, Jain P, Jallouk A, Kaffenberger BH, Khalil M, Lechner MG, Li T, Marr A, McGettigan S, McPherson J, Medina T, Mohindra NA, Olszanski AJ, Oluwole O, Patel SP, Prosek J, Reddy S, Reid P, Ryan J, Ryder M, Salman H, Santomasso B, Shofer S, Sosman JA, Wang Y, Zaha VG, Zucker S, Lyons M, Awotiwon A, Hang L (2024). NCCN Guidelines® Insights: Management of Immunotherapy-Related Toxicities, Version 2.2024. J Natl Compr Canc Netw, 22(9), 582-592. (Read full article)
    2. Zhukovsky S, Rets A, Braaten T, Patel AB (2024). VEXAS without vacuoles: Linking genotype to phenotype. EJHaem, 5(5), 981-986. (Read full article)
    3. Wallace BI, England BR, Baker JF, Rojas J, Sauer BC, Roul P, Kunkel GA, Braaten TJ, Petro A, Mikuls TR, Cannon GW (2023). Lowering Expectations: Glucocorticoid Tapering Among Veterans With Rheumatoid Arthritis Achieving Low Disease Activity on Stable Biologic Therapy. ACR Open Rheumatol, 5(9), 437-442. (Read full article)
    4. Braaten TJ, Brahmer JR, Forde PM, Le D, Lipson EJ, Naidoo J, Schollenberger M, Zheng L, Bingham CO, Shah AA, Cappelli LC (2019). Immune checkpoint inhibitor-induced inflammatory arthritis persists after immunotherapy cessation. Ann Rheum Dis, 79(3), 332-338. (Read full article)
    5. Braaten TJ, Zhang, C, Presson, AP, Breviu, B, Clegg, D, Walsh, JA (2019).  Gender Differences in Psoriatic Arthritis With Fatigue, Pain, Function, and Work Disability. J Psoriasis Psoriatic Arthritis, 4(4), 192-197.
    6. Saxena R, Georgopoulos NA, Braaten TJ, Bjonnes AC, Koika V, Panidis D, Welt CK (2015). Han Chinese polycystic ovary syndrome risk variants in women of European ancestry: relationship to FSH levels and glucose tolerance. Hum Reprod, 30(6), 1454-9. (Read full article)

    Case Report

    1. Calabrese C, Cappelli LC, Kostine M, Kirchner E, Braaten T, Calabrese L (2019). Polymyalgia rheumatica-like syndrome from checkpoint inhibitor therapy: case series and systematic review of the literature. RMD Open, 5(1), e000906. (Read full article)

    Letter

    1. Cappelli LC, Bingham CO, Braaten T, Shah AA (2020). Response to: Correspondence on "Immune checkpoint inhibitor-induced inflammatory arthritis persists after immunotherapy cessation" by Braaten et al. [Letter to the editor]. Ann Rheum Dis, 81(1), e14. (Read full article)